US Press Release
TPI Composites, Inc. Announces Third Quarter 2016 Earnings Results
Highlights
For the quarter ended
- Net sales increased 23.1% to
$198.9 million - Total billings increased 28.0% to
$196.1 million - Net income attributable to common shareholders increased to
$2.2 million or$0.08 per diluted share and net income on a pro forma basis was$2.8 million or$0.08 per diluted share - EBITDA increased to
$11.3 million from$6.3 million in the comparable period in 2015, with an EBITDA margin of 5.7% in the 2016 period compared to 3.9% in 2015 - Adjusted EBITDA increased to
$19.6 million from$7.6 million in the comparable period in 2015, with an adjusted EBITDA margin of 9.9% in the 2016 period compared to 4.7% in 2015
KPIs | Q3'16 | Q3'15 | |
Sets¹ | 581 | 433 | |
Estimated megawatts² | 1,321 | 987 | |
Dedicated manufacturing lines³ | 38 | 29 | |
Manufacturing lines installed⁴ | 32 | 29 | |
Manufacturing lines in startup⁵ | 2 | 7 | |
Manufacturing lines in transition⁶ | - | 10 |
- Number of wind blade sets (which consist of three wind blades) invoiced worldwide in the period.
- Estimated megawatts of energy capacity to be generated by wind blade sets invoiced in the period.
- Number of manufacturing lines dedicated to our customers under long-term supply agreements.
- Number of manufacturing lines installed and either in operation, startup or transition.
- Number of manufacturing lines in a startup phase during the pre-production and production ramp-up period.
- Number of manufacturing lines that were being transitioned to a new wind blade model during the period.
“Our strong operational and financial performance in the third quarter of 2016 underscores our commitment to grow, expand margins and continue to drive down the levelized cost of energy. Our results were driven by increased production across three of our geographic segments as we reported year-over-year increases in net sales, total billings, EBITDA and adjusted EBITDA,” said
Third Quarter 2016 Financial Results
Net sales for the three months ended
Total cost of goods sold for the three months ended
General and administrative expenses for the three months ended
Net income for the three months ended
Net income attributable to common shareholders was
EBITDA for three months ended
Adjusted EBITDA for three months ended
Capital expenditures decreased slightly to
Net debt for the three months ended
2016 Outlook
For 2016, the Company expects:
• Total billings between
• Sets delivered of between 2,147 to 2,162
• Estimated megawatts of sets delivered to be between 4,915 to 4,955
• Dedicated manufacturing lines under long-term contracts at year end of between 44 and 46, up from our previous guidance of 38 to 46.
• Manufacturing lines installed of between 33 and 36
• No manufacturing lines in transition
• Manufacturing lines in startup to be between 3 and 6
• Capital expenditures to be between
• Effective tax rate to be between 25% and 30%
• Depreciation and amortization of between
• Interest expense of between
• Income tax expense of between
• Share-based compensation of between
(1) We have not reconciled our expected total billings to expected net sales as calculated under GAAP because we have not yet finalized calculations necessary to provide the reconciliation, including the expected change in deferred revenue, and as such the reconciliation is not possible without unreasonable efforts.
Conference Call and Webcast Information
About
Forward-Looking Statements
This release contains forward-looking statements which are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements, among other things, concerning: effects on our financial statements and our financial outlook; our business strategy, including anticipated trends and developments in and management plans for our business and the wind industry and other markets in which we operate; competition; future financial results, operating results, revenues, gross margin, operating expenses, products, projected costs, warranties, our ability to improve our operating margins, and capital expenditures. These forward-looking statements are often characterized by the use of words such as "estimate," "expect," "anticipate," "project," "plan," "intend," "seek," "believe," "forecast," "foresee," "likely," "may," "should," "goal," "target," "might," "will," "could," "predict," "continue" and the negative or plural of these words and other comparable terminology. Forward-looking statements are only predictions based on our current expectations and our projections about future events. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these forward-looking statements for any reason. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the matters discussed in "Risk Factors," in our Registration Statement on Form S-1 and other reports that we will file with the
Non-GAAP Definitions
This press release includes unaudited non-GAAP financial measures, including total billings, EBITDA, adjusted EBITDA, net debt and free cash flow. We define total billings as total amounts billed from products and services that we are entitled to payment and have billed under the terms of our long-term supply agreements or other contractual arrangements. We define EBITDA as net income plus interest expense (including losses on extinguishment of debt and net of interest income), income taxes and depreciation and amortization. We define adjusted EBITDA as EBITDA plus any share-based compensation expense plus or minus any gains or losses from foreign currency transactions. We define net debt as the total principal amount of debt outstanding less unrestricted cash and equivalents. We define free cash flow as net cash flow generated from operating activities less capital expenditures. We present non-GAAP measures when we believe that the additional information is useful and meaningful to investors. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similar measures presented by other companies. The presentation of non-GAAP financial measures is not intended to be a substitute for, and should not be considered in isolation from, the financial measures reported in accordance with GAAP. See below for a reconciliation of certain non-GAAP financial measures to the comparable GAAP measures.
| ||||||||||||||
TABLE ONE - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||
(UNAUDITED) | ||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||
($ in thousands, except per share amounts) | 2016 | 2015 | 2016 | 2015 | ||||||||||
Net sales | $ | 198,938 | $ | 161,578 | $ | 569,303 | $ | 406,906 | ||||||
Cost of sales | 171,648 | 150,732 | 499,896 | 370,824 | ||||||||||
Startup and transition costs | 5,088 | 3,011 | 11,449 | 15,546 | ||||||||||
Total cost of goods sold | 176,736 | 153,743 | 511,345 | 386,370 | ||||||||||
Gross profit | 22,202 | 7,835 | 57,958 | 20,536 | ||||||||||
General and administrative expenses | 14,065 | 3,423 | 24,154 | 9,530 | ||||||||||
Income from operations | 8,137 | 4,412 | 33,804 | 11,006 | ||||||||||
Other income (expense): | ||||||||||||||
Interest income | 27 | 11 | 76 | 149 | ||||||||||
Interest expense | (4,663 | ) | (3,620 | ) | (12,709 | ) | (10,894 | ) | ||||||
Realized loss on foreign currency remeasurement | (243 | ) | (1,351 | ) | (700 | ) | (1,621 | ) | ||||||
Miscellaneous income (expense) | (152 | ) | 31 | 192 | 300 | |||||||||
Total other expense | (5,031 | ) | (4,929 | ) | (13,141 | ) | (12,066 | ) | ||||||
Income (loss) before income taxes | 3,106 | (517 | ) | 20,663 | (1,060 | ) | ||||||||
Income tax provision | (309 | ) | (1,630 | ) | (4,565 | ) | (2,734 | ) | ||||||
Net income (loss) | 2,797 | (2,147 | ) | 16,098 | (3,794 | ) | ||||||||
Net income attributable to preferred shareholders | 596 | 2,355 | 5,471 | 7,067 | ||||||||||
Net income (loss) attributable to common shareholders | $ | 2,201 | $ | (4,502 | ) | $ | 10,627 | $ | (10,861 | ) | ||||
Weighted-average common shares outstanding: | ||||||||||||||
Basic | 27,284 | 4,238 | 12,042 | 4,238 | ||||||||||
Diluted | 27,375 | 4,238 | 12,133 | 4,238 | ||||||||||
Basic income (loss) per common share | $ | 0.08 | $ | (1.06 | ) | $ | 0.88 | $ | (2.56 | ) | ||||
Diluted income (loss) per common share | $ | 0.08 | $ | (1.06 | ) | $ | 0.88 | $ | (2.56 | ) | ||||
Non-GAAP Measures: | ||||||||||||||
Total billings | $ | 196,095 | $ | 153,145 | $ | 566,779 | $ | 409,837 | ||||||
EBITDA | $ | 11,272 | $ | 6,253 | $ | 42,999 | $ | 18,156 | ||||||
Adjusted EBITDA | $ | 19,632 | $ | 7,604 | $ | 51,816 | $ | 19,777 | ||||||
| ||||||
TABLE TWO - CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
($ in thousands) | 2016 | 2015 | ||||
(Unaudited) | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 106,802 | $ | 45,917 | ||
Restricted cash | 2,409 | 1,760 | ||||
Accounts receivable | 100,150 | 72,913 | ||||
Inventories | 58,824 | 50,841 | ||||
Inventories held for customer orders | 48,203 | 49,594 | ||||
Prepaid expenses and other current assets | 26,415 | 31,337 | ||||
Total current assets | 342,803 | 252,362 | ||||
Noncurrent assets: | ||||||
Property, plant, and equipment, net | 78,635 | 67,732 | ||||
Other noncurrent assets | 17,655 | 9,826 | ||||
Total assets | $ | 439,093 | $ | 329,920 | ||
Current liabilities: | ||||||
Accounts payable and accrued expenses | $ | 107,319 | $ | 101,108 | ||
Accrued warranty | 31,057 | 13,596 | ||||
Deferred revenue | 61,949 | 65,520 | ||||
Customer deposits and customer advances | 13,775 | 8,905 | ||||
Current maturities of long-term debt | 27,171 | 52,065 | ||||
Total current liabilities | 241,271 | 241,194 | ||||
Noncurrent liabilities: | ||||||
Long-term debt, net of debt issuance costs, discount | ||||||
and current maturities | 83,751 | 77,281 | ||||
Other noncurrent liabilities | 4,287 | 3,812 | ||||
Total liabilities | 329,309 | 322,287 | ||||
Preferred shares and warrants | - | 198,830 | ||||
Shareholders' equity (deficit) | 109,784 | (191,197 | ) | |||
Total liabilities and shareholders' equity (deficit) | $ | 439,093 | $ | 329,920 | ||
Non-GAAP Measure: | ||||||
Net debt | $ | 7,067 | $ | 90,667 |
| |||||||||||||||
TABLE THREE - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||
(UNAUDITED) | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
($ in thousands) | 2016 | 2015 | 2016 | 2015 | |||||||||||
Net cash provided by operating activities | $ | 17,801 | $ | 3,442 | $ | 27,976 | $ | 3,510 | |||||||
Net cash used in investing activities | (4,673 | ) | (4,851 | ) | (18,917 | ) | (25,161 | ) | |||||||
Net cash provided by (used in) financing activities | 63,012 | (3,769 | ) | 52,371 | (14,721 | ) | |||||||||
Impact of foreign exchange rates on cash and cash | |||||||||||||||
equivalents | (395 | ) | (190 | ) | (545 | ) | (263 | ) | |||||||
Cash and cash equivalents, beginning of period | 31,057 | 12,325 | 45,917 | 43,592 | |||||||||||
Cash and cash equivalents, end of period | $ | 106,802 | $ | 6,957 | $ | 106,802 | $ | 6,957 | |||||||
| |||||||||||||
TABLE FOUR - RECONCILIATION OF NON-GAAP MEASURES | |||||||||||||
(UNAUDITED) | |||||||||||||
Total billings is reconciled as follows: | Three Months Ended | Nine Months Ended | |||||||||||
($ in thousands) | 2016 | 2015 | 2016 | 2015 | |||||||||
Net sales | $ | 198,938 | $ | 161,578 | $ | 569,303 | $ | 406,906 | |||||
Change in deferred revenue: | |||||||||||||
Blade-related deferred revenue at beginning of period (1) | (65,656 | ) | (68,226 | ) | (65,520 | ) | (59,476 | ) | |||||
Blade-related deferred revenue at end of period (1) | 61,949 | 56,089 | 61,949 | 56,089 | |||||||||
Foreign exchange impact (2) | 864 | 3,704 | 1,047 | 6,318 | |||||||||
Change in deferred revenue | (2,843 | ) | (8,433 | ) | (2,524 | ) | 2,931 | ||||||
Total billings | $ | 196,095 | $ | 153,145 | $ | 566,779 | $ | 409,837 | |||||
EBITDA and adjusted EBITDA are reconciled as follows: | Three Months Ended | Nine Months Ended | |||||||||||
($ in thousands) | 2016 | 2015 | 2016 | 2015 | |||||||||
Net income (loss) | $ | 2,797 | $ | (2,147 | ) | $ | 16,098 | $ | (3,794 | ) | |||
Adjustments: | |||||||||||||
Depreciation and amortization | 3,530 | 3,161 | 9,703 | 8,471 | |||||||||
Interest expense (net of interest income) | 4,636 | 3,609 | 12,633 | 10,745 | |||||||||
Income tax provision | 309 | 1,630 | 4,565 | 2,734 | |||||||||
EBITDA | 11,272 | 6,253 | 42,999 | 18,156 | |||||||||
Share-based compensation expense | 8,117 | - | 8,117 | - | |||||||||
Realized loss on foreign currency remeasurement | 243 | 1,351 | 700 | 1,621 | |||||||||
Adjusted EBITDA | $ | 19,632 | $ | 7,604 | $ | 51,816 | $ | 19,777 | |||||
Free cash flow is reconciled as follows: | Three Months Ended | Nine Months Ended | |||||||||||
($ in thousands) | 2016 | 2015 | 2016 | 2015 | |||||||||
Net cash provided by operating activities | $ | 17,801 | $ | 3,442 | $ | 27,976 | $ | 3,510 | |||||
Capital expenditures | (4,673 | ) | (4,851 | ) | (18,917 | ) | (25,161 | ) | |||||
Free cash flow | $ | 13,128 | $ | (1,409 | ) | $ | 9,059 | $ | (21,651 | ) | |||
Net debt is reconciled as follows: | |||||||||||||
($ in thousands) | 2016 | 2015 | |||||||||||
Total debt, net of debt issuance costs and discount | $ | 110,922 | $ | 129,346 | |||||||||
Add debt issuance costs | 2,947 | 4,220 | |||||||||||
Add discount on debt | - | 3,018 | |||||||||||
Less cash and cash equivalents | (106,802 | ) | (45,917 | ) | |||||||||
Net debt | $ | 7,067 | $ | 90,667 | |||||||||
(1) Total billings is reconciled using the blade-related deferred revenue amounts at the beginning and the end of the period as follows: | |||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||
($ in thousands) | 2016 | 2015 | 2016 | 2015 | |||||||||
Blade-related deferred revenue at beginning of period | $ | 65,656 | $ | 68,226 | $ | 65,520 | $ | 59,476 | |||||
Non-blade related deferred revenue at beginning of period | - | - | - | - | |||||||||
Total current and noncurrent deferred revenue at beginning of period | $ | 65,656 | $ | 68,226 | $ | 65,520 | $ | 59,476 | |||||
Blade-related deferred revenue at end of period | $ | 61,949 | $ | 56,089 | $ | 61,949 | $ | 56,089 | |||||
Non-blade related deferred revenue at end of period | - | - | - | - | |||||||||
Total current and noncurrent deferred revenue at end of period | $ | 61,949 | $ | 56,089 | $ | 61,949 | $ | 56,089 | |||||
(2) Represents the effect of the difference in the exchange rate used by our various foreign subsidiaries on the invoice date versus the exchange rate | |||||||||||||
used at the period-end balance sheet date. |
Investor Relations 480-315-8742 investors@TPIComposites.comSource: